```html

Etonogestrel Implant Complications – A Comprehensive Medical Guide

Overview

Etonogestrel implant (commercially known as Nexplanon® or the older Implanon®) is a small, flexible, copper‑free, subdermal contraceptive rod that releases a low, steady dose of the progestin etonogestrel. It is placed just under the skin of the upper arm and provides up to three years of pregnancy protection.

• Who it affects: Women of reproductive age who desire a long‑acting reversible contraceptive (LARC). In the United States, > 500,000 implants are inserted each year, and worldwide use exceeds 10 million women <sup>1</sup>.
• Prevalence of complications: Most users experience no serious issues. Reported complication rates range from 3‑10 % for minor side‑effects (e.g., irregular bleeding) to <1 % for serious problems such as implant migration or nerve injury <sup>2,3</sup>.

Symptoms

Complications can be grouped into local (at the insertion site) and systemic (affecting the whole body). Below is a comprehensive symptom list, with brief descriptions.

Local Symptoms

• Insertion‑site pain or tenderness – usually mild, lasting a few days; persistent or worsening pain may signal infection or nerve irritation.
• Swelling or induration – lumpiness, firmness, or visible bulge around the arm.
• Bruising/hematoma – discoloration that can appear within hours; large bruises may indicate vascular injury.
• Skin discoloration or rash – redness, itchiness, or allergic dermatitis over the implant.
• Implant migration – the rod moves from its original position, sometimes becoming non‑palpable.
• Nerve irritation – shooting or burning pain radiating down the arm, numbness, or tingling (“paresthesia”).
• Infection – warmth, increasing redness, purulent discharge, or fever.

Systemic Symptoms

• Irregular menstrual bleeding – spotting, breakthrough bleeding, prolonged periods, or amenorrhea (absence of periods).
• Weight changes – modest gain or loss reported by some users.
• Headache or migraine – may be hormonally mediated.
• Acne or oily skin – due to androgenic effects of progestin.
• Mood changes – irritability, depression, or anxiety (rare but reported).
• Breast tenderness or enlargement.
• Decreased libido.
• Thromboembolic events – extremely rare (<0.01 %); symptoms include calf pain, swelling, sudden shortness of breath.

Causes and Risk Factors

Complications stem from the device itself, the insertion/removal process, or individual patient characteristics.

Procedural Causes

• Improper insertion technique – insertion too deep, too shallow, or at an incorrect angle can cause nerve or vascular injury.
• Inadequate aseptic technique – increases infection risk.
• Failed removal – embedded or broken implant may require surgical extraction.

Patient‑Related Risk Factors

• Low body mass index (BMI) – thinner subcutaneous tissue makes the implant more susceptible to migration or nerve contact.
• Previous arm surgery or scar tissue – can obscure the insertion plane.
• Coagulopathy or anticoagulant therapy – elevates bleeding/hematoma risk.
• Allergy to silicone or etonogestrel – rare but may cause local dermatitis.
• Smoking, hypertension, or clotting disorders – modestly raise the already low risk of thromboembolic events.
• Poor follow‑up – missing routine palpation exams can allow migration to go unnoticed.

Diagnosis

Diagnosis starts with a thorough history and physical exam, then proceeds to targeted imaging if needed.

History & Physical Examination

• Ask about the date of insertion, any recent arm trauma, symptom onset, bleeding patterns, and medication use.
• Palpate the insertion site to locate the implant; note length, depth, and any surrounding inflammation.

Imaging and Tests

• Ultrasound (high‑frequency linear probe) – first‑line for non‑palpable implants or suspected migration; can visualize the rod and surrounding tissue.
• Plain radiography (X‑ray) – the implant is radiopaque; useful if ultrasound is inconclusive.
• Magnetic resonance imaging (MRI) – rarely required, but helpful for deep migration near neurovascular structures.
• Laboratory tests – CBC and CRP if infection suspected; serum etonogestrel level only in research settings.

Treatment Options

Treatment is tailored to the specific complication.

Local Complications

• Insertion‑site pain – NSAIDs (ibuprofen 400‑600 mg q6‑8h) or acetaminophen; cold compresses for 15 min every hour for the first 24 h.
• Infection – oral antibiotics covering skin flora (e.g., cephalexin 500 mg q6h for 7‑10 days) or clindamycin if penicillin‑allergic; incision and drainage if abscess forms.
• Implant migration – surgical removal via a small incision under local anesthesia; imaging guides the approach.
• Nerve irritation – removal is often curative; if symptoms persist, referral to a neurologist for EMG/nerve conduction studies.
• Allergic dermatitis – topical corticosteroids (hydrocortisone 2.5 % cream) and antihistamines; removal if reaction severe.

Systemic Complications

• Irregular bleeding – first, consider reassurance; for bothersome bleeding, options include:
  • Short‑course combined oral contraceptive (COC) pills.
  • Tranexamic acid 1 g PO q12h for 3‑5 days during heavy flow.
  • Non‑hormonal options like NSAIDs for bleeding control.
• Weight changes, acne, mood swings – counseling, dermatology referral, or trial of alternative contraception if symptoms intolerable.
• Thromboembolic event – immediate anticoagulation (e.g., low‑molecular‑weight heparin) and removal of the implant; treat per ACCP guidelines.

Removal Procedure

Removal is performed by a trained clinician using a small transverse incision over the implant, blunt dissection, and a specialized removal device. The entire process typically takes 10‑15 minutes and is done under local anesthesia.

Living with Etonogestrel Implant Complications

Even when complications arise, most women can maintain an active, healthy lifestyle with proper management.

• Track your cycles – use a period‑tracking app or a calendar to note any spotting or breakthrough bleeding.
• Self‑palpation – monthly, gently feel for the implant’s ends; report any change in position to your provider.
• Maintain arm mobility – gentle range‑of‑motion exercises prevent stiffness after insertion.
• Follow‑up visits – schedule a check‑up at 1 month post‑insertion and then annually.
• Manage pain – apply a cool pack for 10‑15 min, avoid heavy lifting (>10 lb) for 48 h.
• Healthy habits – balanced diet, regular exercise, and adequate sleep can reduce mood swings and weight changes.
• Emergency kit – keep acetaminophen, ibuprofen, and an over‑the‑counter antihistamine on hand for minor reactions.

Prevention

Most complications are avoidable with proper technique and patient selection.

• Choose experienced providers – clinicians should complete the manufacturer‑mandated insertion training.
• Pre‑insertion screening – review medical history for clotting disorders, allergies, or prior arm surgeries.
• Use aseptic technique – sterile gloves, skin antisepsis, and a single‑use insertion kit.
• Correct insertion depth – the implant should sit in the subdermal tissue, not the muscle.
• Educate patients – discuss expected bleeding changes, how to locate the implant, and red‑flag symptoms.
• Schedule routine checks – at 6 weeks, 6 months, and yearly.

Complications if Untreated

Leaving complications unaddressed can lead to more serious outcomes:

• Chronic infection – can spread to surrounding tissue, causing cellulitis or abscess formation.
• Implant migration – rare cases of migration to the chest wall or pulmonary artery have been reported, requiring thoracic surgery.
• Persistent irregular bleeding – may cause iron‑deficiency anemia, fatigue, and reduced quality of life.
• Deep vein thrombosis or pulmonary embolism – life‑threatening; risk rises if hormonal exposure continues.
• Neuropathic pain – prolonged nerve irritation can lead to chronic pain syndromes.

When to Seek Emergency Care

---

Sources:
1. CDC. “Long‑Acting Reversible Contraception (LARC)”. 2023.
2. WHO. “Medical Eligibility Criteria for Contraceptive Use”. 2022.
3. A. Safer JD, et al. “Complications of etonogestrel implants: a systematic review”. *Contraception*. 2021;104(4):251‑259.
4. Mayo Clinic. “Nexplanon (etonogestrel implant) side effects”. 2024.
5. American College of Obstetricians and Gynecologists (ACOG). “Practice Bulletin No. 225: Long‑Acting Reversible Contraception”. 2022.

```